Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models

Abstract Neutrophil gelatinase-associated lipocalin (NGAL) is involved in cardiovascular and renal diseases. Gene inactivation of NGAL blunts the pathophysiological consequences of cardiovascular and renal damage. We aimed to design chemical NGAL inhibitors and investigate its effects in experimenta...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benjamin Bonnard, Ernesto Martínez-Martínez, Amaya Fernández-Celis, Marie Pieronne-Deperrois, Quoc-Tuan Do, Isbaal Ramos, Patrick Rossignol, Faiez Zannad, Paul Mulder, Antoine Ouvrard-Pascaud, Natalia López-Andrés, Frédéric Jaisser
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/586ab7e43039448a81137dea9b14ca3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares